Johnson & Johnson spent £37.1 billion on intangible assets and £11.87 billion on R&D last year
Johnson & Johnson has made it to the list of top 10 most innovative companies in the world released by FOREX.com.
The US-based pharmaceutical company is the fourth most innovative company, scoring 8.23/10 in the innovation index.
Johnson & Johnson is the only pharmaceutical company making it to top 10 list, which makes it the world’s most innovative pharmaceutical company in 2023.
The ranking is based on many factors such as the number of US-registered patents in 2022, the number of R&D expenses over the last 12 consecutive months and their last reported intangible assets.
The health giant spent £37.16 billion on intangible assets (the second highest after Apple), £11.87 billion on R&D last year and registered 1,377 patents last year.
Consumer electronic companies dominated the list, securing the top three spots.
Samsung tops the list with an innovation score of 9.25/10 and the highest number of new patents in 2022 (8,513).
Matthew Weller, Head of Global Market Commentary at FOREX.com, said: “The report’s findings underscore Samsung’s dominance in the innovation arena, with its leading number of patents reflecting a significant push in consumer electronics. This patent portfolio is not just a measure of quantity but a marker of Samsung’s potential to disrupt markets and set new industry standards.”
Despite having spent the most on intangible assets out of all companies, Apple slipped to second position in the list, scoring 9.03/10.
IT giant IBM is in the third place with a score of 8.33/10 and the second highest number of new patents registered in 2022 (4743).
Intel invested 31.6 per cent (£13.6 billion) of their £43 billion revenue – the most out of all companies.
E-commerce giant, Amazon, has invested the most in R&D in the last year (£65 billion).
Experts at FOREX.com have prepared the list by analysing data from Harrity and Seeking Alpha to uncover which companies are the most innovative.
